17 results on '"Berkes S"'
Search Results
2. Weak transcranial electrical Direct Current stimulation (tDCS) / Random Noise stimulation (tRNS) during fMRI
- Author
-
Schellhorn, K., Berkes, S., Schlegelmilch, F., Guellmar, D., and Herrmann, K. H.
- Published
- 2009
- Full Text
- View/download PDF
3. EEG-Feedback of slow cortical potentials during fMRI
- Author
-
Schellhorn, K., Schlegelmilch, F., Berkes, S., Guellmar, D., Herrmann, K. H., Windischberger, C., and Fischmeister, F.
- Published
- 2009
- Full Text
- View/download PDF
4. Investigation of artifacts in early transcranial magnetic stimulated responses
- Author
-
Schlegelmilch, F, Berkes, S, and Schellhorn, K
- Published
- 2009
- Full Text
- View/download PDF
5. P237 Feasibility of new stimulator setup for temporal interference TES and its application in a homogeneous volume conductor
- Author
-
Hunold, A., Berkes, S., Schellhorn, K., Antal, A., and Haueisen, J.
- Published
- 2020
- Full Text
- View/download PDF
6. Inventory of current EU paediatric vision and hearing screening programmes
- Author
-
Sloot, F. Hoeve, H.L.J. de Kroon, M.L.A. Goedegebure, A. Carlton, J. Griffiths, H.J. Simonsz, H.J. Langmann, A. Lindner, S. Gaugl, H. ten Tusscher, M. Guérin, C. Hoppenbrouwers, K. van Lammeren, M. Boelaert, K. Godts, D. Paris, V. Bauwens, A. Stateva, D. Petrinovic-Doresic, J. Bjelos, M. Novak-Stroligo, M. Alpeza-Dunato, Z. Gavrielides Michaeloudes, M. Dostálek, M. Zobanova, A. Jerabkova, A. Hesgaard, H. Welinder, L.G. Sandfeld, L. Larsen, S. Levin, M. Klett, A. Somma, K. Ismagilova, S. Hyvärinen, L. Thouvenin, D. Coursager, K. Elflein, H. Pitz, S. Lenk-Schaefer, M. Van-Waveren, M. Ziakas, N.G. Polychroniadis Scouros, S. Knezy, K. Nemeth, J. Soproni, A. Facskó, A. Berkes, S. Gudmundsdottir, E. McCreery, K. Morad, Y. Ancri, O. Nucci, P. Serafino, M. Lembo, A. Bottin, D. Valeina, S. Misevice, A. Asoklis, R.S. Planata-Bogdan, B. Francalanza, M. Sjoerdsma, T. van Rijn, R. Osnes-Ringen, O. Moe, M. Bakunowicz-Lazarczyk, A. Reich-d’Almeida, F. Marques Neves, C. Reich d’Almeida, I. Oliveira, M. Vladutiu, C. Stankovic, B. Djokić, V. Gerinec, A. Stirn Kranjc, B. Gomez-de-Liano Sanchez, R. Rajmil, L. Prats, B. Nilsson, J. Flodin, S. Landau, K. Sturm, V. Zuber, C. Glauser, V. Atilla, H. Horwood, A.M. Williams, C. Shea, S. Griffiths, H. Carlton, J. Qirjazi, B. Gugatschka, M. Stappaerts, L. Vos, B. Milkov, M. Velepic, M. Thodi, C. Syka, J. Ovesen, T. Luht, L. Niemensivu, R. Aarnisalo, A. Denoyelle, F. Keilmann, A. Neumann, K. Nikolopoulos, T. Beke, Z. Hinriksdóttir, I. O’Connor, A. Rubin, L. Trevisi, P. Martini, A. Grandori, F. Kuške, S. Lesinskas, E. Hild, J.M. Fenech, A. Chiaburu, A. Jovicevic, O. Nordfalk, K. Medbø, S. Szyfter, W. Greczka, G. Monteiro, L. Georgescu, M. Filipovic, S.A. Pavlovcinova, G. Profant, M. Battelino, S. Boletezar, I.H. Núñez-Batalla, F. Javier Cervera, O. Uhlén, I. Veraguth, D. Atilla, H. Carr, G. Davis, A. Bruderer, A. Sirimanna, T. Qirjazi, B. Roshi, E. Hoppenbrouwers, K. Guérin, C. Georgieva, L. Rukavina, T. Bourek, A. Hietanen-Peltola, M. Jégat, C. Ottová-Jordan, V. Polychroniadis Scouros, S. Kovacs, A. Jónsdóttir, L.S. Morad, Y. Grotto, I. Farrugia, S.V. Memeti, S. Mugosa, B. Raat, H. Gaspar, T. Zivkovic, S.M. Juricic, M. Rajmil, L. Hjern, A. Atilla, H. Dahlmann-Noor, A. Gouder, M.J. Jovovic, N. Pojuzina, N. EUS€REEN study group
- Abstract
Objective: To examine the diversity in paediatric vision and hearing screening programmes in Europe. Methods: Themes for comparison of screening programmes derived from literature were used to compile three questionnaires on vision, hearing, and public health screening. Tests used, professions involved, age, and frequency of testing seem to influence sensitivity, specificity, and costs most. Questionnaires were sent to ophthalmologists, orthoptists, otolaryngologists, and audiologists involved in paediatric screening in all EU full-member, candidate, and associate states. Answers were cross-checked. Results: Thirty-nine countries participated; 35 have a vision screening programme, 33 a nation-wide neonatal hearing screening programme. Visual acuity (VA) is measured in 35 countries, in 71% of these more than once. First measurement of VA varies from three to seven years of age, but is usually before age five. At age three and four, picture charts, including Lea Hyvarinen, are used most; in children over four, Tumbling-E and Snellen. As first hearing screening test, otoacoustic emission is used most in healthy neonates, and auditory brainstem response in premature newborns. The majority of hearing testing programmes are staged; children are referred after 1–4 abnormal tests. Vision screening is performed mostly by paediatricians, ophthalmologists, or nurses. Funding is mostly by health insurance or state. Coverage was reported as >95% in half of countries, but reporting was often not first-hand. Conclusion: Largest differences were found in VA charts used (12), professions involved in vision screening (10), number of hearing screening tests before referral (1–4), and funding sources (8). © 2015, The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
- Published
- 2015
7. Inventory of current EU paediatric vision and hearing screening programmes
- Author
-
Sloot, Frea, Hoeve, Hans LJ, de Kroon, Marlou LA, Goedegebure, André, Carlton, Jill, Griffiths, Helen J, Simonsz, Huibert J, Langmann, A., Lindner, S., Gaugl, H., ten Tusscher, M., Guérin, C., Hoppenbrouwers, K., van Lammeren, M., Boelaert, K., Godts, D., Paris, V., Bauwens, A., Stateva, D., Petrinovic Doresic, J., Bjelos, M., Novak Stroligo, M., Alpeza Dunato, Z., Gavrielides Michaeloudes, M., Dostálek, M., Zobanova, A., Jerabkova, A., Hesgaard, H., Welinder, L. G., Sandfeld, L., Larsen, S., Levin, M., Klett, A., Somma, K., Ismagilova, S., Hyvärinen, L., Thouvenin, D., Coursager, K., Elflein, H., Pitz, S., Lenk Schaefer, M., Van Waveren, M., Ziakas, N. G., Polychroniadis Scouros, S., Knezy, K., Nemeth, J., Soproni, A., Facskó, A., Berkes, S., Gudmundsdottir, E., Mccreery, K., Morad, Y., Ancri, O., Nucci, P., Serafino, M., Lembo, A., Bottin, D., Valeina, S., Misevice, A., Asoklis, R. S., Planata Bogdan, B., Francalanza, M., Sjoerdsma, T., van Rijn, R., Osnes Ringen, O., Moe, M., Bakunowicz Lazarczyk, A., Reich d’Almeida, F., Marques Neves, C., Reich d’Almeida, I., Oliveira, M., Vladutiu, C., Stankovic, B., Djokić, V., Gerinec, A., Stirn Kranjc, B., Gomez de Liano Sanchez, R., Rajmil, L., Prats, B., Nilsson, J., Flodin, S., Landau, K., Sturm, V., Zuber, C., Glauser, V., Atilla, H., Horwood, A. M., Williams, C., Shea, S., Griffiths, H., Carlton, J., Qirjazi, Birkena, Gugatschka, Markus, Stappaerts, Luc, Vos, Bénédicte, Milkov, Mario, Velepic, Marko, Thodi, Chryssoula, Syka, Josef, Ovesen, Therese, Luht, Liina, Niemensivu, Riina, Aarnisalo, Antii, Denoyelle, Françoise, Keilmann, Annerose, Neumann, Katrin, Nikolopoulos, Thomas, Beke, Zsolt, Hinriksdóttir, Ingibjörg, O’Connor, Ann, Rubin, Lisa, Trevisi, Patrizia, Martini, Alessandro, Grandori, Ferdinando, Kuške, Sandra, Lesinskas, Eugenijus, Hild, Jean Marc, Fenech, Anthony, Chiaburu, Anghelina, Jovicevic, Ognjen, Nordfalk, Karl, Medbø, Sverre, Szyfter, Witold, Greczka, Grazyna, Monteiro, Luisa, Georgescu, Madalina, Filipovic, Snezana Andric, Pavlovcinova, Gabriela, Profant, Milan, Battelino, Saba, Boletezar, Irena Hocevar, Núñez Batalla, Faustino, Javier Cervera, Oviedo, Uhlén, Inger, Veraguth, Dorothe, Atilla, Huban, Carr, Gwen, Davis, Adrian, Bruderer, Adam, Sirimanna, Tony, Qirjazi, B., Roshi, E., Georgieva, L., Rukavina, T., Bourek, A., Hietanen Peltola, M., Jégat, C., Ottová Jordan, V., Kovacs, A., Jónsdóttir, L. S., Grotto, I., Farrugia, Sant'Angelo V., Memeti, S., Mugosa, B., Raat, H., Gaspar, T., Zivkovic, Sulovic M., Juricic, M., Hjern, A., Dahlmann Noor, A., Gouder, M. J., Jovovic, N., Pojuzina, N., Public Health Research (PHR), Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Public Health, Neuroprotection & Neuromodulation, and Surgical clinical sciences
- Subjects
screening, vision, hearing, EU, prevention, paediatric ,medicine.medical_specialty ,vision ,Visual acuity ,paediatric ,Referral ,genetic structures ,Otoacoustic Emissions, Spontaneous ,CHILDHOOD ,Visual Acuity ,CHILDREN ,Audiology ,EU ,hearing ,prevention ,screening ,Health Policy ,Public Health, Environmental and Occupational Health ,Hearing screening ,Vision Screening ,SDG 3 - Good Health and Well-being ,AMBLYOPIA ,Journal Article ,medicine ,Evoked Potentials, Auditory, Brain Stem ,media_common.cataloged_instance ,Humans ,COHORT ,European Union ,European union ,Child ,media_common ,business.industry ,Public health ,Hearing Tests ,Environmental and Occupational Health ,IMPAIRMENT ,Test (assessment) ,Auditory brainstem response ,Child, Preschool ,Cohort ,Female ,Public Health ,medicine.symptom ,business ,COSTS - Abstract
Objective To examine the diversity in paediatric vision and hearing screening programmes in Europe. Methods Themes for comparison of screening programmes derived from literature were used to compile three questionnaires on vision, hearing, and public health screening. Tests used, professions involved, age, and frequency of testing seem to influence sensitivity, specificity, and costs most. Questionnaires were sent to ophthalmologists, orthoptists, otolaryngologists, and audiologists involved in paediatric screening in all EU full-member, candidate, and associate states. Answers were cross-checked. Results Thirty-nine countries participated; 35 have a vision screening programme, 33 a nation-wide neonatal hearing screening programme. Visual acuity (VA) is measured in 35 countries, in 71% of these more than once. First measurement of VA varies from three to seven years of age, but is usually before age five. At age three and four, picture charts, including Lea Hyvarinen, are used most; in children over four, Tumbling-E and Snellen. As first hearing screening test, otoacoustic emission is used most in healthy neonates, and auditory brainstem response in premature newborns. The majority of hearing testing programmes are staged; children are referred after 1–4 abnormal tests. Vision screening is performed mostly by paediatricians, ophthalmologists, or nurses. Funding is mostly by health insurance or state. Coverage was reported as >95% in half of countries, but reporting was often not first-hand. Conclusion Largest differences were found in VA charts used (12), professions involved in vision screening (10), number of hearing screening tests before referral (1–4), and funding sources (8).
- Published
- 2015
- Full Text
- View/download PDF
8. Low thyroxine levels in female psychiatric inpatients with riboflavin deficiency: implications for folate-dependent methylation.
- Author
-
Bell, I. R., Morrow, F.D., Read, M., Berkes, S., and Perrone, G.
- Published
- 1992
- Full Text
- View/download PDF
9. ADAPTIVE SNR-ANHEBUNG VON VEP MIT STATISTIK HÖHERER ORDNUNG.
- Author
-
Husar, P., Berkes, S., Götze, A., Henning, G., and Plagwitz, K. -U.
- Published
- 2003
- Full Text
- View/download PDF
10. Prolonged hemolysis from overheated dialysate.
- Author
-
Berkes, Stephen L., Khan, Sewell I., Chazan, Joseph A., Garella, Serafino, Berkes, S L, Kahn, S I, Chazan, J A, and Garella, S
- Subjects
ACUTE kidney failure ,HEMODIALYSIS ,ERYTHROCYTES - Abstract
A patient with chronic renal failure exposed to overheated dialysate (50 degrees C) for 20 minutes developed evidence of delayed and protracted hemolysis, which continued for several days. By contrast, in the only previously reported similar case, sudden gross hemolysis followed by cardiac arrest occurred. It is emphasized that the rapidity and severity of hemolysis due to thermal injury to erythrocytes are dependent upon the duration of exposure and the height of temperature to which extracorporeal blood is exposed. Methods of preventing such incidents and therapeutic approaches are outlined. [ABSTRACT FROM AUTHOR]
- Published
- 1975
- Full Text
- View/download PDF
11. A mobile electrical stimulator for therapeutic modulation of the vestibular system - design, safety, and functionality.
- Author
-
Kollmansperger S, Decker J, Berkes S, Jahn K, and Wuehr M
- Abstract
Low-intensity noisy galvanic vestibular stimulation (nGVS) is a promising non-invasive treatment for enhancing vestibular perceptual performance and postural control in patients with chronic vestibular hypofunction. However, this approach has so far been studied mainly under laboratory conditions. Evidence indicates that continuous application of nGVS in daily life is necessary for it to be effective. To address this need, we have developed a mobile nGVS stimulator and conducted a series of pilot studies to evaluate its safety, tolerability, functionality, and therapeutic effects. The device is a lightweight, compact, and portable AC stimulator featuring a user-friendly interface for the individualized adjustment of nGVS parameters. It includes an integrated motion sensor that automatically activates stimulation during body movement and deactivates it during inactivity, optimizing its practical use in real-world settings. The stimulator adheres to strict safety standards and, in initial long-term use, has exhibited only mild side effects (e.g., skin irritation and headaches), likely attributable to the current electrode placement, which requires further optimization. As expected, the device consistently elicits known vestibular sensorimotor reflex responses in healthy individuals. Importantly, further pilot studies in healthy participants demonstrate that the device can reliably replicate known facilitating effects on vestibular perception and postural control. Together, these findings suggest that this mobile stimulation device can facilitate the translation of nGVS into therapeutic everyday use., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2024 Kollmansperger, Decker, Berkes, Jahn and Wuehr.)
- Published
- 2024
- Full Text
- View/download PDF
12. Reply to Letter to the Editor by Kaya C, et al.
- Author
-
Pardy C, Berkes S, D'Souza R, Fox G, Davidson JR, and Yardley IE
- Published
- 2024
- Full Text
- View/download PDF
13. Complete Resection of Necrotic Bowel Improves Survival in NEC Without Compromising Enteral Autonomy.
- Author
-
Pardy C, Berkes S, D'Souza R, Fox G, Davidson JR, and Yardley IE
- Subjects
- Humans, Infant, Newborn, Intestine, Small surgery, Intestines surgery, Intestines pathology, Laparotomy methods, Retrospective Studies, Enterocolitis, Necrotizing, Infant, Newborn, Diseases surgery, Intestinal Diseases complications
- Abstract
Aims: Controversy persists regarding operative strategy for necrotising enterocolitis (NEC). Some surgeons advocate resecting all necrotic bowel, whilst others defunction with a stoma, leaving diseased bowel in situ to preserve bowel length. We reviewed our institutional experience of both approaches., Methods: Neonates undergoing laparotomy for NEC May 2015-2019 were identified. Data extracted from electronic records included: demographics, neonatal Sequential Organ Failure Assessment (nSOFA) score at surgery, operative findings, and procedure performed. Neonates were assigned to two groups according to operative strategy: complete resection of necrotic bowel (CR) or necrotic bowel left in situ (LIS). Primary outcome was survival, and secondary outcome was enteral autonomy. Outcomes were compared between groups., Results: Fifty neonates were identified. Six were excluded: 4 with NEC totalis and 2 with no visible necrosis or histological confirmation of NEC. Of the 44 remaining neonates, 27 were in the CR group and 17 in the LIS group. 32 neonates survived to discharge (73%). On univariate analysis, survival was associated with lower nSOFA score (P = 0.003), complete resection of necrotic bowel (OR 9.0, 95% CI [1.94-41.65]), and being born outside the surgical centre (OR 5.11 [1.23-21.28]). On Cox regression multivariate analysis, complete resection was still strongly associated with survival (OR 4.87 [1.51-15.70]). 28 of the 32 survivors (88%) achieved enteral autonomy. There was no association between operative approach and enteral autonomy (P = 0.373), or time to achieve this., Conclusion: Complete resection of necrotic bowel during surgery for NEC significantly improves likelihood of surviving without negatively impacting remaining bowel function., Level of Evidence: III., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
14. Impact of using less objective symptoms to define tolerated dose during food challenges: A data-driven approach.
- Author
-
Turner PJ, Patel N, Blumchen K, Berkes S, Sampson HA, and Beyer K
- Subjects
- Humans, Reproducibility of Results, Allergens, Immunotherapy methods, Peanut Hypersensitivity diagnosis, Food Hypersensitivity diagnosis
- Abstract
Background: Food challenges (FCs) form the basis for assessing efficacy outcomes in interventional studies of food allergy; however, different studies have used a variety of similar but not identical criteria to define a challenge reaction, including subjective (nonobjective) symptoms occurring in a single-organ system as dose limiting., Objective: Our aim was to undertake a secondary analysis of 4 interventional studies to assess the impact of using less objective criteria to determine challenge-stop on reaction thresholds and their reproducibility., Methods: We analyzed individual participant data, including individual participant data meta-analysis, by using 3 different published challenge-stop criteria: (1) PRACTALL consesus criteria; (2) Consortium for Food Allergy Research version 3 (CoFAR v3) with at least 1 moderate- or severe-grade symptom; or (3) CoFAR v3 with at least 2 mild symptoms occurring in different organ systems. Reproducibility of challenge threshold was also assessed in participants undergoing subsequent repeat FCs., Results: Four studies, with detailed challenge data from a total of 592 participants, were included. Applying CoFAR v3 definitions for dose-limiting symptoms resulted in an underestimate of reaction thresholds compared with those in PRACTALL (P < .001) that is equivalent to almost a single dosing increment when using a semi-log dosing regimen. Reproducibility was also reduced when applying CoFAR v3 (P < .001 [n = 223]). Using the least conservative interpretation of CoFAR v3 (≥2 mild symptoms occurring in different systems) resulted in a significant overestimate of 15% when assessing oral immunotherapy efficacy. Applying a data-driven minor modification to CoFAR v3 resulted in a new set of challenge-stop criteria with validity similar to that of PRACTALL but one that is simpler to implement and in which significant gastrointestinal discomfort with observable decreased activity remains a dose-limiting symptom., Conclusion: The use of less objective symptoms to define challenge-stop compromises the reproducibility of the FC as a tool to assess efficacy outcomes in interventional studies, and potentially overestimates the efficacy of the intervention tested., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
15. The impact of the COVID-19 pandemic on UK medical education. A nationwide student survey.
- Author
-
Tekkis NP, Rafi D, Brown S, Courtney A, Kawka M, Howell AM, McLean K, Gardiner M, Mavroveli S, Hutchinson P, Tekkis P, Wilkinson P, Sam AH, Savva N, Kontovounisios C, Tekkis N, Rafi D, Brown S, Courtney A, Kawka M, Howell A, McLean K, Gardiner M, Mavroveli S, Hutchinson P, Tekkis P, Wilkinson P, Sam AH, Savva N, Kontovounisios C, Tekkis N, Rafi D, Brown S, Courtney A, Kawka M, Howell A, McLean K, Gardiner M, Mavroveli S, Hutchinson P, Tekkis P, Wilkinson P, Sam AH, Savva N, Kontovounisios C, Tekkis N, Brown S, Kawka M, Mclean K, Savva N, Wilkinson P, Sam AH, Singal A, Chia C, Chia W, Ganesananthan S, Ooi SZY, Pengelly S, Wellington J, Mak S, Subbiah Ponniah H, Heyes A, Aberman I, Ahmed T, Al-Shamaa S, Appleton L, Arshad A, Awan H, Baig Q, Benedict K, Berkes S, Citeroni NL, Damani A, de Sancha A, Fisayo T, Gupta S, Haq M, Heer B, Jones A, Khan H, Kim H, Meiyalagan N, Miller G, Minta N, Mirza L, Mohamed F, Ramjan F, Read P, Soni L, Tailor V, Tas RN, Vorona M, Walker M, Winkler T, Bardon A, Acquaah J, Ball T, Bani W, Elmasry A, Hussein F, Kolluri M, Lusta H, Newman J, Nott M, Perwaiz MI, Rayner R, Shah A, Shaw I, Yu K, Cairns M, Clough R, Gaier S, Hirani D, Jeyapalan T, Li Y, Patel CR, Shabir H, Wang YA, Weatherhead A, Dhiran A, Renney O, Wells P, Ferguson S, Joyce A, Mergo A, Adebayo O, Ahmad J, Akande O, Ang G, Aniereobi E, Awasthi S, Banjoko A, Bates J, Chibada C, Clarke N, Craner I, Desai DD, Dixon K, Duffaydar HI, Kuti M, Mughal AZ, Nair D, Pham MC, Preest GG, Reid R, Sachdeva GS, Selvaratnam K, Sheikh J, Soran V, Stoney N, Wheatle M, Howarth K, Knapp-Wilson A, Lee KS, Mampitiya N, Masson C, McAlinden JJ, McGowan N, Parmar SC, Robinson B, Wahid S, Willis L, Risquet R, Adebayo A, Dhingra L, Kathiravelupillai S, Narayanan R, Soni J, Ghafourian P, Hounat A, Lennon KA, Abdi Mohamud M, Chou W, Chong L, Graham CJ, Piya S, Riad AM, Vennard S, Wang J, Kawar L, Maseland C, Myatt R, Tengku Saifudin TNS, Yong SQ, Douglas F, Ogbechie C, Sharma K, Zafar L, Bajomo MO, Byrne MHV, Obi C, Oluyomi DI, Patsalides MA, Rajananthanan A, Richardson G, Clarke A, Roxas A, Adeboye W, Argus L, McSweeney J, Rahman-Chowdhury M, Hettiarachchi DS, Masood MT, Antypas A, Thomas M, de Andres Crespo M, Zimmerman M, Dhillon A, Abraha S, Burton O, Jalal AHB, Bailey B, Casey A, Kathiravelupillai A, Missir E, Boult H, Campen D, Collins JM, Dulai S, Elhassan M, Foster Z, Horton E, Jones E, Mahapatra S, Nancarrow T, Nyamapfene T, Rimmer A, Robberstad M, Robson-Brown S, Saeed A, Sarwar Y, Taylor C, Vetere G, Whelan MK, Williams J, Zahid D, Chand C, and Matthews M
- Subjects
- Humans, Pandemics, Students, United Kingdom epidemiology, COVID-19 epidemiology, Education, Medical, Students, Medical
- Published
- 2022
- Full Text
- View/download PDF
16. Description of five dirofilariasis cases in South Hungary and review epidemiology of this disease for the country.
- Author
-
Dóczi I, Bereczki L, Gyetvai T, Fejes I, Skribek Á, Szabó Á, Berkes S, Tiszlavicz L, Bartha N, Bende B, Kis E, and Kucsera I
- Subjects
- Adult, Aged, Dirofilariasis therapy, Female, Humans, Hungary epidemiology, Male, Middle Aged, Pregnancy, Pregnancy Complications therapy, Prevalence, Risk Factors, Dirofilariasis diagnosis, Dirofilariasis epidemiology, Pregnancy Complications diagnosis, Pregnancy Complications epidemiology
- Abstract
Background: Dirofilariasis is an emerging zoonosis (supported by climate change) in Central Europe. Human infections are usually caused by Dirofilaria repens and Dirofilaria immitis with mediation of mosquito vectors. Aims of this publication were to report our dirofilariasis cases, and to summarize Hungarian epidemiological data by reviewing literature., Methods and Results: We present five (four ophthalomological, one subcutaneous) cases observed within a 2-year period in Southern Hungary. Ages of infected patients were between 31 and 74 years. First case during pregnancy is also reported. There was no travel history in the anamnesis of patients which could explain acquisition of the infection. Moving, intact worms eliminated by surgical interventions were identified on the basis of morphological features as D. repens. Since the first report of human case, 115 further episodes (in addition to ours) were diagnosed in Hungary. Mean age of the patients was 47 years. Reviewing national reports, the ratio of subcutaneous infections was higher than that of the ocular ones (66 and 45, respectively). Evaluation of the territorial distribution of human episodes revealed that most infections occurred in patients living in the Danube-Tisza interfluvial region and eastern part of the country. However, sporadic cases were also found in western counties during 2014., Conclusion: Most of the Hungarian dirofilariasis cases were autochthonous infections. Occurrence in the western counties may suggest the spreading of this emerging zoonosis to these areas. Comprehensive monitoring and data analysis are desirable, therefore reporting the epidemiologic data in the case of human infections should be made mandatory.
- Published
- 2015
- Full Text
- View/download PDF
17. Contrast media-induced oliguric renal failure.
- Author
-
Alexander RD, Berkes SL, and Abuelo G
- Subjects
- Adult, Age Factors, Aged, Angiocardiography, Celiac Artery diagnostic imaging, Diabetes Complications, Humans, Middle Aged, Urography, Acute Kidney Injury chemically induced, Anuria chemically induced, Diatrizoate adverse effects, Oliguria chemically induced
- Abstract
Seven patients had acute oliguric renal failure after intravenous urography (2), celiac arteriography (2), or cardiac angiography (3). Diatrizoate meglumine was the contrast media used in all of the cases. These patients had an average age of 63 years and six were 55 years of age or older. Diabetes mellitus, negative fluid balance before the procedure, underlying renal insufficiency, and hypertension were common, being present in three, four, five, and six of the patients respectively . Anuria or oliguria occurred within 24 hours of the procedure and persisted from 36 to 96 hours (72 hours average). The serum creatinine level rose significantly in all of the patients and reached a peak in two to seven days after the procedure. In six patients, recovery was complete by two to three weeks. The seventh patient experienced only partial recovery. These cases taken together with a mounting number of recent reports suggest that contrast media-induced oliguric renal failure is more common than generally believed. Diabetes mellitus, older age, and underlying renal insufficiency seem to be important predisposing factors.
- Published
- 1978
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.